Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity.
Journal: Frontiers in immunology
Published: February 11, 2025
Toll-like receptors 2, 4, and 9 modulate promoting effect of COPD-like airway inflammation on K-ras-driven lung cancer through activation of the MyD88/NF-ĸB pathway in the airway epithelium.
Journal: Frontiers in immunology
Published: December 07, 2022
Lung Cancer Murine Models and Methodology for Immunopreventive Study.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 07, 2022
Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras-mutant lung cancer.
Journal: JCI insight
Published: December 20, 2021
Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer.
Journal: Carcinogenesis
Published: March 18, 2020
Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment.
Journal: Frontiers in oncology
Published: October 14, 2019
COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation.
Journal: Oncotarget
Published: February 08, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026